Assisted conception following poor ovarian response to gonadotrophin stimulation.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 9422028)

Published in Br J Obstet Gynaecol on December 01, 1997

Authors

A Gorgy, N Naumann, S Bates, I L Craft

Associated clinical trials:

Clinical Trial to Assess the Effect of Testosterone in Patients With Poor Ovarian Response (TESTOPRIM) (TESTOPRIM) | NCT03378713

Articles cited by this

Assisted conception following poor ovarian response to gonadotrophin stimulation. Br J Obstet Gynaecol (1997) 2.12

Articles by these authors

The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J (1998) 6.08

Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet (2000) 5.50

p14ARF links the tumour suppressors RB and p53. Nature (1998) 4.78

2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol (2001) 3.25

A population of fast radio bursts at cosmological distances. Science (2013) 3.03

Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product. EMBO J (1995) 2.26

Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant. EMBO J (1996) 2.12

Gamete intrafallopian transfer in older women: effect of limiting number of gametes transferred. BMJ (1994) 2.03

Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function. Mol Cell Biol (1996) 1.99

Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia. N Engl J Med (1986) 1.79

Absorption and malabsorption of glycine and glycine peptides in man. Gut (1968) 1.73

Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins. Lancet (1984) 1.71

Absorption of glycine and glycine peptides from the small intestine of the rat. Clin Sci (1968) 1.69

Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA (1998) 1.67

Mdm2 binds p73 alpha without targeting degradation. Oncogene (1999) 1.62

Induction of DNA synthesis and apoptosis are separable functions of E2F-1. Genes Dev (1997) 1.59

Two individuals with elliptocytic red cells apparently lack three minor erythrocyte membrane sialoglycoproteins. Biochem J (1984) 1.56

Low concentrations of the histone deacetylase inhibitor, depsipeptide (FR901228), increase expression of the Na(+)/I(-) symporter and iodine accumulation in poorly differentiated thyroid carcinoma cells. J Clin Endocrinol Metab (2001) 1.54

Intraoperative mannitol does not prevent renal failure in orthotopic liver transplantation. Crit Care Resusc (2001) 1.40

Limiting multiple births. Lancet (2000) 1.37

EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma. J Clin Oncol (1993) 1.34

E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways. Mol Cell (1999) 1.34

Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins. Oncogene (1995) 1.34

Functional characterization of the human multidrug transporter, ABCG2, expressed in insect cells. Biochem Biophys Res Commun (2001) 1.33

Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein in the cell lines of the National Cancer Institute Anticancer Drug Screen. J Clin Invest (1995) 1.30

Continuous lumbar epidural analgesia using bupivicaine: a study of the fetus and newborn child. J Obstet Gynaecol Br Commonw (1971) 1.29

Accumulation of p16INK4a in mouse fibroblasts as a function of replicative senescence and not of retinoblastoma gene status. Oncogene (1997) 1.27

Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal function. Mol Psychiatry (2009) 1.22

Pretreatment with DNA-damaging agents permits selective killing of checkpoint-deficient cells by microtubule-active drugs. J Clin Invest (2000) 1.22

A comparison between quarter, partial and total laser assisted hatching in selected infertility patients. Hum Reprod (2001) 1.18

Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion. J Clin Oncol (1994) 1.18

Injuries of the cervix after induced midtrimester abortion. J Obstet Gynaecol Br Commonw (1973) 1.18

Analysis of the evolution of chromosome abnormalities in human embryos from Day 3 to 5 using CGH and FISH. Mol Hum Reprod (2008) 1.12

Will GnRH antagonists provide new hope for patients considered 'difficult responders' to GnRH agonist protocols? Hum Reprod (1999) 1.12

8th San Antonio Breast Cancer Symposium--Plenary lecture. Autocrine and paracrine growth regulation of human breast cancer. Breast Cancer Res Treat (1986) 1.11

Hypercoagulability in patients with primary biliary cirrhosis and primary sclerosing cholangitis evaluated by thrombelastography. J Hepatol (1997) 1.10

Morphology of acute promyelocytic leukemia with cytogenetic or molecular evidence for the diagnosis: characterization of additional microgranular variants. Am J Hematol (1997) 1.09

Amplification of 4q21-q22 and the MXR gene in independently derived mitoxantrone-resistant cell lines. Genes Chromosomes Cancer (2000) 1.09

Primary care and population factors associated with NHS Health Check coverage: a national cross-sectional study. J Public Health (Oxf) (2013) 1.08

Autocrine and paracrine growth regulation of human breast cancer. J Steroid Biochem (1986) 1.06

Perturbation of the p53 response by human papillomavirus type 16 E7. J Virol (1997) 1.06

Enhanced adenovirus transgene expression in malignant cells treated with the histone deacetylase inhibitor FR901228. Cancer Res (2001) 1.05

Evidence from a salvaged treatment cycle supports an aetiology for the empty follicle syndrome that is related to terminal follicular developmental events. Hum Reprod (1997) 1.05

Free perforation of the small bowel due to regional enteritis. Br J Surg (1967) 1.05

Intramural pregnancy following difficult embryo transfer. Hum Reprod (1994) 1.01

Extracellular protein kinase A as a cancer biomarker: its expression by tumor cells and reversal by a myristate-lacking Calpha and RIIbeta subunit overexpression. Proc Natl Acad Sci U S A (2000) 1.00

A children's acute respiratory illness scale (CARIFS) predicted functional severity and family burden. J Clin Epidemiol (2004) 1.00

Sequence-specific and domain-specific DNA repair in xeroderma pigmentosum and Cockayne syndrome cells. J Biol Chem (1997) 0.99

Optimal insulin delivery in adolescents with diabetes: impact of intensive treatment on psychosocial adjustment. Diabetes Care (1984) 0.98

Does short-term antiepileptic drug treatment in children result in cognitive or behavioral changes? Epilepsia (1998) 0.98

Growth regulation of human breast carcinoma occurs through regulated growth factor secretion. J Cell Biochem (1987) 0.96

Utilization of retrieved oocytes as an index of the efficiency of superovulation strategies for in-vitro fertilization treatment. Hum Reprod (1997) 0.95

Cerebrovascular arteriopathy (arteriosclerosis) and ischemic childhood stroke. Stroke (1982) 0.94

Inhibitors of platelet aggregation in the fetoplacental unit and myometrium with particular reference to the ADP-degrading property of placenta. Placenta (1981) 0.94

Inhibition of platelet aggregation by placental extracts. Thromb Res (1980) 0.94

Studies of percutaneous epididymal sperm aspiration (PESA) and intracytoplasmic sperm injection. Hum Reprod Update (1998) 0.93

The late appearance of extramedullary lesions in myelomatosis. Br J Cancer (1967) 0.92

Carcinoma of the tongue in early adult life. Br J Cancer (1967) 0.92

Candida albicans GRX2, encoding a putative glutaredoxin, is required for virulence in a murine model. Genet Mol Res (2007) 0.91

Prostaglandin E2 compared with oxytocin for the induction of labour. Br Med J (1971) 0.91

Phase I study of infusional paclitaxel in combination with the P-glycoprotein antagonist PSC 833. J Clin Oncol (2001) 0.91

Results of percutaneous epididymal sperm aspiration and intracytoplasmic sperm injection in two major groups of patients with obstructive azoospermia. Hum Reprod (1997) 0.91

Routine induction of labour with extra-amniotic prostaglandin E2 in a viscous gel. Br J Obstet Gynaecol (1979) 0.89

The influence of pregnancy and lactation on the morphology and absorptive capacity of the rat small intestine. Clin Sci (1970) 0.89

Effect of an education programme on the utilization of a medical emergency team in a teaching hospital. Intern Med J (2006) 0.89

Self-rating of pain in nonulcer dyspepsia. A methodological study comparing a new fixed-point scale and the visual analogue scale. J Clin Gastroenterol (1987) 0.88

Functional characterization of the Candida albicans MNT1 mannosyltransferase expressed heterologously in Pichia pastoris. J Biol Chem (2000) 0.88

Candida cell wall mannosylation: importance in host-fungus interaction and potential as a target for the development of antifungal drugs. Biochem Soc Trans (1999) 0.88

A phase I dose escalation study of the matrix metalloproteinase inhibitor BAY 12-9566 administered orally in patients with advanced solid tumours. Ann Oncol (2000) 0.87

The transcription-repair coupling factor CSA is required for efficient repair only during the elongation stages of RNA polymerase II transcription. Mutat Res (1998) 0.87

Stroke genomics: approaches to identify, validate, and understand ischemic stroke gene expression. J Cereb Blood Flow Metab (2001) 0.87

The efficacy of local anaesthesia for percutaneous epididymal sperm aspiration and testicular sperm aspiration. Hum Reprod (1998) 0.87

Utility of percutaneous epididymal sperm aspiration in situations of unexpected obstructive azoospermia. Hum Reprod (1997) 0.86

Efflux of rhodamine from CD56+ cells as a surrogate marker for reversal of P-glycoprotein-mediated drug efflux by PSC 833. Blood (1999) 0.86

Resistance to paclitaxel mediated by P-glycoprotein can be modulated by changes in the schedule of administration. Cancer Chemother Pharmacol (1997) 0.86

Oocyte donation in 61 patients. Lancet (1989) 0.85

A high-resolution analysis of chromatin structure along p53 sequences. Mol Carcinog (1996) 0.85

Using the national cancer institute anticancer drug screen to assess the effect of MRP expression on drug sensitivity profiles. Mol Pharmacol (1998) 0.85

[Postoperative syndrome after spine surgery]. Radiologe (2006) 0.85

Phase II study of paclitaxel in relapsed non-Hodgkin's lymphomas. J Clin Oncol (1995) 0.85

Depression in child psychiatric inpatients: cognitive and attributional patterns. J Abnorm Child Psychol (1988) 0.84

Gestational surrogacy: a feasible option for patients with Rokitansky syndrome. Hum Reprod (2000) 0.84

Ovum donation--a simplified approach. Fertil Steril (1987) 0.84

Antiperistaltic segment of jejunum for persistent diarrhea following vagotomy. Ann Surg (1968) 0.83

Growth regulatory peptide production by human breast carcinoma cells. J Steroid Biochem (1988) 0.83

Radiofrequency thermal ablation of a splenic metastasis. J Vasc Interv Radiol (2001) 0.83

Intestinal absorption of saccharides and peptides. Lancet (1968) 0.82

Registration of pain in a psychological perspective. Scand J Gastroenterol Suppl (1985) 0.82

The value of single versus repeated insemination in intra-uterine donor insemination cycles. Hum Reprod (1995) 0.82

Pediatric victims of unexplained stroke and their families: familial lipid and lipoprotein abnormalities. Pediatrics (1982) 0.82

Oral contraceptives and amino acid utilization. Am J Obstet Gynecol (1970) 0.81

Recurrent venous thrombosis and heparin therapy: an evaluation of the importance of early activated partial thromboplastin times. Arch Intern Med (1999) 0.81

Cobalamins in human pregnancy and lactation. J Clin Pathol (1971) 0.81

The multiple faces of the partial thromboplastin time APTT. J Thromb Haemost (2004) 0.80